Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clint Cary

Showing results (121-130 of 123) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 123 results.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2023
Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort studyLuca Antonelli, Davide Ardizzone, Praful Ravi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2023
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual CancerLuca Antonelli, Davide Ardizzone, Isamu Tachibana, et al.
BJU International|December 11, 2024
Primary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumourLuca Antonelli, Axel Heidenreich, Aditya Bagrodia, et al.
Pageof 13

Showing results (121-130 of 123) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 123 results.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2023
Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort studyLuca Antonelli, Davide Ardizzone, Praful Ravi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2023
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual CancerLuca Antonelli, Davide Ardizzone, Isamu Tachibana, et al.
BJU International|December 11, 2024
Primary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumourLuca Antonelli, Axel Heidenreich, Aditya Bagrodia, et al.
Pageof 13